Journal article

SOCS2 negatively regulates growth hormone action in vitro and in vivo

CJ Greenhalgh, E Rico-Bautista, M Lorentzon, AL Thaus, PO Morgan, TA Willson, P Zervoudakis, D Metcalf, I Street, NA Nicola, AD Nash, LJ Fabri, G Norstedt, C Ohlsson, A Flores-Morales, WS Alexander, DJ Hilton

Journal of Clinical Investigation | Published : 2005

Abstract

Mice deficient in SOCS2 display an excessive growth phenotype characterized by a 30-50% increase in mature body size. Here we show that the SOCS2 -/- phenotype is dependent upon the presence of endogenous growth hormone (GH) and that treatment with exogenous GH induced excessive growth in mice lacking both endogenous GH and SOCS2. This was reflected in terms of overall body weight, body and bone lengths, and the weight of internal organs and tissues. A heightened response to GH was also measured by examining GH-responsive genes expressed in the liver after exogenous GH administration. To further understand the link between SOCS2 and the GH-signaling cascade, we investigated the nature of the..

View full abstract

University of Melbourne Researchers